Literature DB >> 30326765

Understanding extracellular vesicle diversity - current status.

David W Greening1, Richard J Simpson1.   

Abstract

INTRODUCTION: Extracellular vesicles (EVs) represent an important mode of intercellular communication. There is now a growing awareness that predominant EV subtypes; exosomes from endosomal origin, and shed microvesicles from plasma membrane budding, can be further stratified into distinct subtypes, however specific approaches in their isolation and markers that allow them to be discriminated are lacking. Areas covered: Knowledge about these distinct EV subpopulations is important including the regulation of composition, release, targeting/localization, uptake, and function. This review discusses the mechanisms of distinct EV biogenesis and release, defining select EV classes (and subpopulations), which will be crucial for development of EV-based functions and clinical applications. We review the dynamics of cargo sorting leading to the mechanisms of EV heterogeneity, their mechanisms of formation, intracellular trafficking pathways, and provide an uptake about biochemical/functional differences. With advances in purification strategies and proteomic-based quantitation, allows significant benefit in accurately describing differences in EV protein cargo composition and modification. Expert commentary: The advent of quantitative mass spectrometry-based proteomics, in conjunction with advances in molecular cell biology, and EV purification strategies, has contributed significantly to our improved characterization and understanding of the molecular composition and functionality of these distinct EV subpopulations.

Keywords:  Extracellular vesicles; biogenesis; heterogeneity; secretion

Mesh:

Year:  2018        PMID: 30326765     DOI: 10.1080/14789450.2018.1537788

Source DB:  PubMed          Journal:  Expert Rev Proteomics        ISSN: 1478-9450            Impact factor:   3.940


  40 in total

Review 1.  Making sense of gut feelings in the traumatic brain injury pathogenesis.

Authors:  Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Neurosci Biobehav Rev       Date:  2019-05-16       Impact factor: 8.989

Review 2.  Exosome release and cargo in Down syndrome.

Authors:  Eric D Hamlett; Angela LaRosa; Elliott J Mufson; Juan Fortea; Aurélie Ledreux; Ann-Charlotte Granholm
Journal:  Dev Neurobiol       Date:  2019-08-06       Impact factor: 3.964

3.  A Protocol for Isolation, Purification, Characterization, and Functional Dissection of Exosomes.

Authors:  Alin Rai; Haoyun Fang; Monique Fatmous; Bethany Claridge; Qi Hui Poh; Richard J Simpson; David W Greening
Journal:  Methods Mol Biol       Date:  2021

4.  Analysis of Annotated and Unannotated Long Noncoding RNAs from Exosome Subtypes Using Next-Generation RNA Sequencing.

Authors:  Wittaya Suwakulsiri; Maoshan Chen; David W Greening; Rong Xu; Richard J Simpson
Journal:  Methods Mol Biol       Date:  2021

5.  EMAPII: A Key Player in HIV-Nef-induced Pulmonary Vasculopathy.

Authors:  Elya A Shamskhou; Leah Verghese; Ke Yuan; Vinicio A de Jesus Perez
Journal:  Am J Respir Cell Mol Biol       Date:  2019-03       Impact factor: 6.914

Review 6.  Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application.

Authors:  Zhen Zhao; Jia Fan; Yen-Michael S Hsu; Christopher J Lyon; Bo Ning; Tony Y Hu
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

7.  Measurement and standardization challenges for extracellular vesicle therapeutic delivery vectors.

Authors:  Bryant C Nelson; Samantha Maragh; Ionita C Ghiran; Jennifer C Jones; Paul C DeRose; Elzafir Elsheikh; Wyatt N Vreeland; Lili Wang
Journal:  Nanomedicine (Lond)       Date:  2020-09-04       Impact factor: 5.307

8.  Major Determinants of Airway Epithelial Cell Sensitivity to S. aureus Alpha-Toxin: Disposal of Toxin Heptamers by Extracellular Vesicle Formation and Lysosomal Degradation.

Authors:  Nils Möller; Sabine Ziesemer; Christian Hentschker; Uwe Völker; Jan-Peter Hildebrandt
Journal:  Toxins (Basel)       Date:  2021-02-24       Impact factor: 4.546

Review 9.  Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.

Authors:  Jeremy P Bost; Hanna Barriga; Margaret N Holme; Audrey Gallud; Marco Maugeri; Dhanu Gupta; Taavi Lehto; Hadi Valadi; Elin K Esbjörner; Molly M Stevens; Samir El-Andaloussi
Journal:  ACS Nano       Date:  2021-09-10       Impact factor: 15.881

Review 10.  Extracellular vesicle therapy for retinal diseases.

Authors:  Ben Mead; Stanislav Tomarev
Journal:  Prog Retin Eye Res       Date:  2020-03-10       Impact factor: 19.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.